ClinicalTrials.Veeva

Menu

Catheter Ablation Versus Medical Treatment of AF in Heart Failure (CAMTAF)

B

Barts & The London NHS Trust

Status

Unknown

Conditions

Atrial Fibrillation
Heart Failure

Treatments

Drug: Medical treatment alone
Procedure: Catheter ablation of persistent atrial fibrillation

Study type

Interventional

Funder types

Other

Identifiers

NCT01411371
05/Q0605/47

Details and patient eligibility

About

Heart failure and atrial fibrillation (AF) often coexist, and each increases the morbidity and mortality associated with the other. The investigators hypothesized that restoration of normal sinus rhythm by catheter ablation is superior to medical treatment of AF in heart failure. This study randomizes patients with heart failure and persistent AF to medical treatment of AF or catheter ablation to restore sinus rhythm.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Persistent atrial fibrillation
  • Symptomatic heart failure

Exclusion criteria

  • Reversible causes of heart failure
  • Contraindications to catheter ablation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Catheter Ablation
Experimental group
Description:
Catheter ablation of persistent atrial fibrillation to restore normal sinus rhythm.
Treatment:
Procedure: Catheter ablation of persistent atrial fibrillation
Medical treatment alone
Active Comparator group
Description:
Patients are randomised to medical treatment alone for atrial fibrillation. Treatment will be as per current guidelines for persistent atrial fibrillation, with rate control as first line (using beta-blockers, calcium channel blockers and digoxin as indicated) and rhythm control as second line (using sotalol, dronedarone, or amiodarone as indicated). (Both groups will receive standard heart failure medication including angiotensin converting enzyme inhibitors, beta blockers, aldosterone antagonists, and diuretics as indicated).
Treatment:
Drug: Medical treatment alone

Trial contacts and locations

1

Loading...

Central trial contact

Ross J Hunter, MRCP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems